Trial intelligence / Profile preview

Pimecrolimus cream 1% for long-term treatment of pediatric atopic dermatitis

NCT00509990Phase 4Completed

Sponsor
Novartis
Start
Apr 2005
Primary completion
Sep 2007
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), sponsored by Novartis. Started Apr 2005; status: completed.

02

Drugs

Pimecrolimus vehicle + topical corticosteroid
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT00509990.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00509990.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call